• bitcoinBitcoin(BTC)$76,715.00-1.26%
  • ethereumEthereum(ETH)$2,240.05-0.76%
  • tetherTether(USDT)$1.00-0.03%
  • binancecoinBNB(BNB)$694.59-1.87%
  • rippleXRP(XRP)$1.25-0.02%
  • usd-coinUSDC(USDC)$1.00-0.01%
  • solanaSolana(SOL)$91.05-3.05%
  • tronTRON(TRX)$0.3168891.42%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.050.00%
  • HyperliquidHyperliquid(HYPE)$83.14-4.22%
  • zcashZcash(ZEC)$1,140.01-6.35%
  • dogecoinDogecoin(DOGE)$0.073376-2.23%
  • moneroMonero(XMR)$602.631.90%
  • USDSUSDS(USDS)$1.00-0.02%
  • whitebitWhiteBIT Coin(WBT)$73.67-1.20%
  • leo-tokenLEO Token(LEO)$9.39-0.13%
  • chainlinkChainlink(LINK)$11.02-3.12%
  • cardanoCardano(ADA)$0.186663-2.34%
  • stellarStellar(XLM)$0.163206-2.31%
  • bitcoin-cashBitcoin Cash(BCH)$275.38-1.57%
  • nearNEAR Protocol(NEAR)$3.86-9.43%
  • daiDai(DAI)$1.00-0.03%
  • Ethena USDeEthena USDe(USDE)$1.00-0.04%
  • RainRain(RAIN)$0.006286-8.31%
  • uniswapUniswap(UNI)$6.98-1.86%
  • litecoinLitecoin(LTC)$53.69-2.59%
  • USD1USD1(USD1)$1.00-0.13%
  • CantonCanton(CC)$0.092843-4.86%
  • avalanche-2Avalanche(AVAX)$8.29-4.09%
  • suiSui(SUI)$0.87-2.77%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.17-3.79%
  • tether-goldTether Gold(XAUT)$3,923.861.38%
  • hedera-hashgraphHedera(HBAR)$0.069125-3.11%
  • Global DollarGlobal Dollar(USDG)$1.00-0.01%
  • quant-networkQuant(QNT)$192.70-1.82%
  • paypal-usdPayPal USD(PYUSD)$1.000.03%
  • shiba-inuShiba Inu(SHIB)$0.000005-3.15%
  • BittensorBittensor(TAO)$221.32-4.57%
  • crypto-com-chainCronos(CRO)$0.050064-2.52%
  • Ripple USDRipple USD(RLUSD)$1.000.01%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.15-0.03%
  • EthenaEthena(ENA)$0.169782-5.81%
  • okbOKB(OKB)$108.17-4.72%
  • Circle USYCCircle USYC(USYC)$1.140.01%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • pepePepe(PEPE)$0.000005-3.78%
  • aaveAave(AAVE)$126.56-5.29%
  • MemeCoreMemeCore(M)$0.84-0.05%
  • OndoOndo(ONDO)$0.382589-4.55%
  • Falcon USDFalcon USD(USDF)$0.99-0.05%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

MIT Researchers Unveil InfoCORE: A Machine Learning Approach to Overcome Batch Effects in High-Throughput Drug Screening

January 20, 2024
in AI & Technology
Reading Time: 4 mins read
A A
MIT Researchers Unveil InfoCORE: A Machine Learning Approach to Overcome Batch Effects in High-Throughput Drug Screening
ShareShareShareShareShare

Recent studies have shown that representation learning has become an important tool for drug discovery and biological system understanding. It is a fundamental component in the identification of drug mechanisms, the prediction of drug toxicity and activity, and the identification of chemical compounds linked to disease states.

The limitation arises in representing the complex interplay between a small molecule’s chemical structure and its physical or biological characteristics. Several molecular representation learning techniques currently in use solely encode a molecule’s chemical identification, leading to unimodal representations, which has drawbacks as molecules with comparable structures can have remarkably diverse functions within a biological setting.

Recent efforts have concentrated on training models that apply multimodal contrastive learning to map 2D chemical structures to high-content cell microscope pictures. In biotechnology, high-throughput drug screening is essential for assessing and understanding the relationship between a drug’s chemical structure and biological activity. This method uses gene expression measures or cell imaging to indicate drug effects. 

However, handling batch effects presents a major challenge when running large-scale screens, necessitating their division into many trials. The appropriate interpretation of results may be hampered by these batch effects, which can potentially incorporate systematic mistakes and non-biological connections into the data. 

To overcome this, a team of researchers has recently presented InfoCORE, an Information maximization strategy for COnfounder REmoval. Effectively managing batch effects and improving the caliber of molecular representations derived from high-throughput drug screening data are the main goals of InfoCORE. Given a batch identifier, the method sets a variational lower bound on the conditional mutual information of latent representations. It does this by adaptively reweighting samples to equalize their inferred batch distribution.

Extensive tests on drug screening data have shown that InfoCORE performs better than other algorithms on a variety of tasks, such as retrieving molecule-phenotype and predicting chemical properties. This implies that InfoCORE successfully reduces the influence of batch effects, resulting in better performance in tasks pertaining to molecular analysis and drug discovery.

The study has also emphasized on how flexible InfoCORE is as a framework that can handle more complex issues. It has shown how InfoCORE can manage shifts in the general distribution and data fairness problems by reducing correlation with bogus characteristics or eliminating sensitive attributes. InfoCORE’s versatility makes it a powerful tool for tackling a variety of challenges connected to data distribution and fairness, in addition to removing the batch effect in drug screening.

The researchers have summarized their primary contributions as follows.

  1. The InfoCORE approach aims to propose a multimodal molecular representation learning framework that can smoothly integrate chemical structures with a variety of high-content drug screens.
  1. The research provides a strong theoretical foundation by demonstrating that InfoCORE maximizes the variational lower bound on the conditional mutual information of the representation given the batch identifier.
  1. InfoCORE has demonstrated its efficiency in molecular property prediction and molecule-phenotype retrieval tasks by consistently outperforming several baseline models in real-world studies.
  1. InfoCORE’s information maximization philosophy extends beyond the field of drug development. Empirical evidence supports its effectiveness in removing sensitive information for representation fairness, making it a flexible tool with wider uses.

Check out the Paper and Github. All credit for this research goes to the researchers of this project. Also, don’t forget to follow us on Twitter. Join our 36k+ ML SubReddit, 41k+ Facebook Community, Discord Channel, and LinkedIn Group.

If you like our work, you will love our newsletter..

Don’t Forget to join our Telegram Channel


YOU MAY ALSO LIKE

Physicians Preferred AI Discharge Summaries in 95% of Cases in Stony Brook Study – Unite.AI

This Samsung Galaxy Problem Sadly Still Exists In 2026, But You Can Easily Fix It

Tanya Malhotra is a final year undergrad from the University of Petroleum & Energy Studies, Dehradun, pursuing BTech in Computer Science Engineering with a specialization in Artificial Intelligence and Machine Learning.
She is a Data Science enthusiast with good analytical and critical thinking, along with an ardent interest in acquiring new skills, leading groups, and managing work in an organized manner.


🐝 Join the Fastest Growing AI Research Newsletter Read by Researchers from Google + NVIDIA + Meta + Stanford + MIT + Microsoft and many others…


Credit: Source link

ShareTweetSendSharePin

Related Posts

Physicians Preferred AI Discharge Summaries in 95% of Cases in Stony Brook Study – Unite.AI
AI & Technology

Physicians Preferred AI Discharge Summaries in 95% of Cases in Stony Brook Study – Unite.AI

November 2, 2026
This Samsung Galaxy Problem Sadly Still Exists In 2026, But You Can Easily Fix It
AI & Technology

This Samsung Galaxy Problem Sadly Still Exists In 2026, But You Can Easily Fix It

November 2, 2026
OpenAI Launches Grid Protectors Program for Compute Campuses – Unite.AI
AI & Technology

OpenAI Launches Grid Protectors Program for Compute Campuses – Unite.AI

November 2, 2026
Why It’s Important To Use A microSD Express Card With Your Nintendo Switch 2
AI & Technology

Why It’s Important To Use A microSD Express Card With Your Nintendo Switch 2

November 2, 2026
Next Post
The #etf decision helps bring #bitcoin mainstream, says Coinbase CFO #technology #shorts

The #etf decision helps bring #bitcoin mainstream, says Coinbase CFO #technology #shorts

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
Sutter Health suddenly abandons  billion Emeryville hospital plan

Sutter Health suddenly abandons $1 billion Emeryville hospital plan

October 30, 2026
Researcher in Russia dies after potential plague exposure

Researcher in Russia dies after potential plague exposure

November 1, 2026
What Is Flow Matching? A Faster Path for Generative AI – Unite.AI

What Is Flow Matching? A Faster Path for Generative AI – Unite.AI

October 31, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!